Literature DB >> 17429487

Recombinant adeno-associated virus targets passenger gene expression to cones in primate retina.

Katherine Mancuso1, Anita E Hendrickson, Thomas B Connor, Matthew C Mauck, James J Kinsella, William W Hauswirth, Jay Neitz, Maureen Neitz.   

Abstract

Recombinant adeno-associated virus (rAAV) is a promising vector for gene therapy of photoreceptor-based diseases. Previous studies have demonstrated that rAAV serotypes 2 and 5 can transduce both rod and cone photoreceptors in rodents and dogs, and it can target rods, but not cones in primates. Here we report that using a human cone-specific enhancer and promoter to regulate expression of a green fluorescent protein (GFP) reporter gene in an rAAV-5 vector successfully targeted expression of the reporter gene to primate cones, and the time course of GFP expression was able to be monitored in a living animal using the RetCam II digital imaging system.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17429487     DOI: 10.1364/josaa.24.001411

Source DB:  PubMed          Journal:  J Opt Soc Am A Opt Image Sci Vis        ISSN: 1084-7529            Impact factor:   2.129


  17 in total

1.  Impact of Heparan Sulfate Binding on Transduction of Retina by Recombinant Adeno-Associated Virus Vectors.

Authors:  Sanford L Boye; Antonette Bennett; Miranda L Scalabrino; K Tyler McCullough; Kim Van Vliet; Shreyasi Choudhury; Qing Ruan; James Peterson; Mavis Agbandje-McKenna; Shannon E Boye
Journal:  J Virol       Date:  2016-03-28       Impact factor: 5.103

2.  Adapting to altered image statistics using processed video.

Authors:  Michael Falconbridge; David Wozny; Ladan Shams; Stephen A Engel
Journal:  Vision Res       Date:  2009-04-11       Impact factor: 1.886

3.  Dosage thresholds for AAV2 and AAV8 photoreceptor gene therapy in monkey.

Authors:  Luk H Vandenberghe; Peter Bell; Albert M Maguire; Cassia N Cearley; Ru Xiao; Roberto Calcedo; Lili Wang; Michael J Castle; Alexandra C Maguire; Rebecca Grant; John H Wolfe; James M Wilson; Jean Bennett
Journal:  Sci Transl Med       Date:  2011-06-22       Impact factor: 17.956

4.  Retinal gene therapy using adeno-associated viral vectors: multiple applications for a small virus.

Authors:  William W Hauswirth
Journal:  Hum Gene Ther       Date:  2014-08       Impact factor: 5.695

5.  Synthetic Adeno-Associated Viral Vector Efficiently Targets Mouse and Nonhuman Primate Retina In Vivo.

Authors:  Livia S Carvalho; Ru Xiao; Sarah J Wassmer; Aliete Langsdorf; Eric Zinn; Simon Pacouret; Samiksha Shah; Jason I Comander; Leo A Kim; Laurence Lim; Luk H Vandenberghe
Journal:  Hum Gene Ther       Date:  2018-03-20       Impact factor: 5.695

6.  The human rhodopsin kinase promoter in an AAV5 vector confers rod- and cone-specific expression in the primate retina.

Authors:  Shannon E Boye; John J Alexander; Sanford L Boye; Clark D Witherspoon; Kristen J Sandefer; Thomas J Conlon; Kirsten Erger; Jingfen Sun; Renee Ryals; Vince A Chiodo; Mark E Clark; Christopher A Girkin; William W Hauswirth; Paul D Gamlin
Journal:  Hum Gene Ther       Date:  2012-09-20       Impact factor: 5.695

7.  Gene therapy for red-green colour blindness in adult primates.

Authors:  Katherine Mancuso; William W Hauswirth; Qiuhong Li; Thomas B Connor; James A Kuchenbecker; Matthew C Mauck; Jay Neitz; Maureen Neitz
Journal:  Nature       Date:  2009-09-16       Impact factor: 49.962

8.  Differential targeting of feline photoreceptors by recombinant adeno-associated viral vectors: implications for preclinical gene therapy trials.

Authors:  A L Minella; F M Mowat; K L Willett; D Sledge; J T Bartoe; J Bennett; S M Petersen-Jones
Journal:  Gene Ther       Date:  2014-07-24       Impact factor: 5.250

Review 9.  The use of canine models of inherited retinal degeneration to test novel therapeutic approaches.

Authors:  William A Beltran
Journal:  Vet Ophthalmol       Date:  2009 May-Jun       Impact factor: 1.644

10.  Longitudinal evaluation of expression of virally delivered transgenes in gerbil cone photoreceptors.

Authors:  Matthew C Mauck; Katherine Mancuso; James A Kuchenbecker; Thomas B Connor; William W Hauswirth; Jay Neitz; Maureen Neitz
Journal:  Vis Neurosci       Date:  2008 May-Jun       Impact factor: 3.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.